![]() |
![]() |
Legal status
Patent revoked (after opposition at EPO)
(51) | INT.CL. | A61K 31/519 | (2006.01) |
A61P 17/04 | (2006.01) | ||
A61P 37/00 | (2006.01) |
(11) | Number of the document | 2874630 |
(13) | Kind of document | T |
(96) | European patent application number | 13742573.2 |
Date of filing the European patent application | 2013-07-18 | |
(97) | Date of publication of the European application | 2015-05-27 |
(45) | Date of publication and mention of the grant of the patent | 2018-12-05 |
(46) | Date of publication of the claims translation | 2019-02-11 |
(86) | Number | PCT/US2013/051015 |
Date | 2013-07-18 |
(87) | Number | WO 2014/015107 |
Date | 2014-01-23 |
(30) | Number | Date | Country code |
201261674289 P | 2012-07-20 | US | |
201361815803 P | 2013-04-25 | US |
(72) |
GONZALES, Andrea J., US
COSGROVE, Sallie B., US
MALPAS, Phyllis B., US
STEGEMANN, Michael Rolf, BE
COLLARD, Wendy Turner, US
|
(73) |
Zoetis Services LLC,
10 Sylvan Way, Parsippany, NJ 07054,
US
|
(74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
(54) | Janus kinazės (JAK) inhibitorių dozavimas |
DOSING REGIMEN FOR JANUS KINASE (JAK) INHIBITORS |
Payment date | Validity (years) | Amount | |
2023-06-23 | 11 | 289.00 EUR |
Patent revoked (after opposition at EPO) | ||
Invalidation date | 2023-10-17 |